FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Vesely

Research Profile

Chemicals & Drugs

Procedures

Radioimmunoassay

Physiology

Natriuresis

Disorders

Anatomy

Tumor Cell Line

Concepts & Ideas

Living Beings

Mouse
Rats

Co-author Network

Publications

TOP 3
David L Vesely
Natriuretic peptides' metabolic targets for treatment of cancer.
Meghan L Lane; Jennifer P Nguyen; Michelle Skelton; William P Skelton; Chelsea D Frost; David L Vesely
Potent selective inhibition of STAT 3 versus STAT 1 by cardiac hormones.
Anne Lenz; Meghan Bennett; William P Skelton; David L Vesely
Vessel dilator and C-type natriuretic peptide enhance the proliferation of human osteoblasts.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Vesely (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: David L Vesely
Natriuretic peptides' metabolic targets for treatment of cancer.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2013;61(5):816-22.
2012: Meghan L Lane; Jennifer P Nguyen; Michelle Skelton; William P Skelton; Chelsea D Frost; David L Vesely
Potent selective inhibition of STAT 3 versus STAT 1 by cardiac hormones.
Molecular and cellular biochemistry 2012;371(1-2):209-15.
2010: Anne Lenz; Meghan Bennett; William P Skelton; David L Vesely
Vessel dilator and C-type natriuretic peptide enhance the proliferation of human osteoblasts.
Pediatric research 2010;68(5):405-8.
2010: Ying Sun; Ehrentraud J Eichelbaum; Anne Lenz; Hai Wang; David L Vesely
Epidermal growth factor's activation of Ras is inhibited by four cardiac hormones.
European journal of clinical investigation 2010;40(5):408-13.
2010: A Lenz; Ying Sun; Ehrentraud J Eichelbaum; W P Skelton; G Pi; David L Vesely
Cardiac hormones eliminate some human squamous lung carcinomas in athymic mice.
European journal of clinical investigation 2010;40(3):242-9.
2010: Anne Lenz; Ying Sun; Ehrentraud J Eichelbaum; William P Skelton; Guillermo Pi; David L Vesely
Twice-weekly intravenous treatment of pancreatic cancer with atrial natriuretic peptide and vessel dilator.
In vivo (Athens, Greece) 2010;24(2):125-9.
2009: Ying Sun; Ehrentraud J Eichelbaum; Anne Lenz; William P Skelton; Hai Wang; David L Vesely
Atrial natriuretic peptide and long-acting natriuretic peptide inhibit ras in human prostate cancer cells.
Anticancer research 2009;29(6):1889-93.
2009: Ying Sun; Ehrentraud J Eichelbaum; William P Skelton; Anne Lenz; Hai Wang; David L Vesely
Vessel dilator and kaliuretic peptide inhibit Ras in human prostate cancer cells.
Anticancer research 2009;29(4):971-5.
2009: Ying Sun; Ehrentraud J Eichelbaum; Hai Wang; David L Vesely
Cardiac hormones activate ERK 1/2 kinases in human fibroblasts.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2009;41(3):197-201.
2009: David L Vesely
Cardiac and renal hormones: anticancer effects in vitro and in vivo.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2009;57(1):22-8.
2008: Ehrentraud J Eichelbaum; Ying Sun; Abdel A Alli; William R Gower; David L Vesely
Cardiac and kidney hormones cure up to 86% of human small-cell lung cancers in mice.
European journal of clinical investigation 2008;38(8):562-70.
2007: Ying Sun; Ehrentraud J Eichelbaum; Hai Wang; David L Vesely
Atrial natriuretic peptide and long acting natriuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells.
Anticancer research 2007;27(6B):3813-8.
2007: David L Vesely; Brian A Vesely; Ehrentraud J Eichelbaum; Ying Sun; Abdel A Alli; William R Gower
Four cardiac hormones eliminate up to two-thirds of human breast cancers in athymic mice.
In vivo (Athens, Greece) 2007;21(6):973-8.
2007: Brian A Vesely; Ehrentraud J Eichelbaum; Abdel A Alli; Ying Sun; William R Gower; David L Vesely
Four cardiac hormones cause cell death of melanoma cells and inhibit their DNA synthesis.
The American journal of the medical sciences 2007;334(5):342-9.
2007: Brian A Vesely; Ehrentraud J Eichelbaum; Abdel A Alli; Ying Sun; William R Gower; David L Vesely
Four cardiac hormones eliminate 4-fold more human glioblastoma cells than the green mamba snake peptide.
Cancer letters 2007;254(1):94-101.
2007: Ying Sun; Ehrentraud J Eichelbaum; Hai Wang; David L Vesely
Vessel dilator and kaliuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells.
Anticancer research 2007;27(3B):1387-92.
2007: David L Vesely; Ehrentraud J Eichelbaum; Ying Sun; Abdel A Alli; Brian A Vesely; Stephen L Luther; William R Gower
Elimination of up to 80% of human pancreatic adenocarcinomas in athymic mice by cardiac hormones.
In vivo (Athens, Greece) 2007;21(3):445-51.
2006: Ehrentraud J Eichelbaum; Brian A Vesely; Abdel A Alli; Ying Sun; William R Gower; David L Vesely
Four cardiac hormones eliminate up to 82% of human medullary thyroid carcinoma cells within 24 hours.
Endocrine 2006;30(3):325-32.
2006: Ying Sun; Ehrentraud J Eichelbaum; Hai Wang; David L Vesely
Atrial natriuretic peptide and long acting natriuretic peptide inhibit ERK 1/2 in prostate cancer cells.
Anticancer research 2006;26(6B):4143-8.
2006: Brian A Vesely; Ehrentraud J Eichelbaum; Abdel A Alli; Ying Sun; William R Gower; David L Vesely
Urodilatin and four cardiac hormones decrease human renal carcinoma cell numbers.
European journal of clinical investigation 2006;36(11):810-9.
2006: Ying Sun; Ehrentraud J Eichelbaum; Hai Wang; David L Vesely
Vessel dilator and kaliuretic peptide inhibit ERK 1/2 activation in human prostate cancer cells.
Anticancer research 2006;26(5A):3217-22.
2006: David L Vesely
Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer?
Clinical and experimental pharmacology & physiology 2006;33(3):169-76.
2006: Brian A Vesely; Shannon R Fitz; William R Gower; David L Vesely
Vessel dilator: most potent of the atrial natriuretic peptides in decreasing the number and DNA synthesis of human squamous lung cancer cells.
Cancer letters 2006;233(2):226-31.
2006: Brian A Vesely; Abdel A Alli; Shijie Song; Juan Sanchez-Ramos; Shannon R Fitz; William R Gower; David L Vesely
Primary malignant tumors of the heart: four cardiovascular hormones decrease the number and DNA synthesis of human angiosarcoma cells.
Cardiology 2006;105(4):226-33.
2005: David L Vesely
Atrial natriuretic peptides: anticancer agents.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2005;53(7):360-5.
2005: Brian A Vesely; Abdel A Alli; S J Song; William R Gower; Juan Sanchez-Ramos; David L Vesely
Four peptide hormones' specific decrease (up to 97%) of human prostate carcinoma cells.
European journal of clinical investigation 2005;35(11):700-10.
2005: Sabiha R Saba; Amanda H Garces; Linda C Clark; John Soto; William R Gower; David L Vesely
Immunocytochemical localization of atrial natriuretic peptide, vessel dilator, long-acting natriuretic peptide, and kaliuretic peptide in human pancreatic adenocarcinomas.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2005;53(8):989-95.
2005: Brian A Vesely; Shijie Song; Juan Sanchez-Ramos; Shannon R Fitz; Abdel A Alli; Suzanne M Solivan; William R Gower; David L Vesely
Five cardiac hormones decrease the number of human small-cell lung cancer cells.
European journal of clinical investigation 2005;35(6):388-98.
2005: William R Gower; Brian A Vesely; Abdel A Alli; David L Vesely
Four peptides decrease human colon adenocarcinoma cell number and DNA synthesis via cyclic GMP.
International journal of gastrointestinal cancer 2005;36(2):77-87.
2005: Brian A Vesely; Shijie Song; Juan Sanchez-Ramos; Shannon R Fitz; Suzanne M Solivan; William R Gower; David L Vesely
Four peptide hormones decrease the number of human breast adenocarcinoma cells.
European journal of clinical investigation 2005;35(1):60-9.
2004: David L Vesely; Linda C Clark; A H Garces; Quentin McAfee; J Soto; William R Gower
Novel therapeutic approach for cancer using four cardiovascular hormones.
European journal of clinical investigation 2004;34(10):674-82.
2004: Darrell R Sawmiller; Robert J Henning; Javier Cuevas; Wayne I DeHaven; David L Vesely
Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart.
Neuropeptides 2004;38(5):289-97.
2004: Shyam S Mohapatra; Richard F Lockey; David L Vesely; William R Gower
Natriuretic peptides and genesis of asthma: an emerging paradigm?
The Journal of allergy and clinical immunology 2004;114(3):520-6.
2004: John R Dietz; Carol S Landon; Stanley J Nazian; David L Vesely; William R Gower
Effects of cardiac hormones on arterial pressure and sodium excretion in NPRA knockout mice.
Experimental biology and medicine (Maywood, N.J.) 2004;229(8):813-8.
2004: Hamang Patel; John R Dietz; Ashley Owen; Gloria San Miguel; Michael T McCormick; Douglas D Schocken; David L Vesely
Combined treatment with vessel dilator and kaliuretic hormone in persons with congestive heart failure.
Experimental biology and medicine (Maywood, N.J.) 2004;229(6):521-7.
2003: Brian A Vesely; Quentin McAfee; William R Gower; David L Vesely
Four peptides decrease the number of human pancreatic adenocarcinoma cells.
European journal of clinical investigation 2003;33(11):998-1005.
2003: William R Gower; Gloria I San Miguel; Gay M Carter; Imran Hassan; Robert V Farese; David L Vesely
Atrial natriuretic hormone prohormone gene expression in cardiac and extra-cardiac tissues of diabetic Goto-Kakizaki rats.
Molecular and cellular biochemistry 2003;252(1-2):263-71.
2003: John R Dietz; David L Vesely; William R Gower; Carol S Landon; Sook Jeong Lee; Stanley J Nazian
Neutralization of proANP (1-30) exacerbates hypertension in the spontaneously hypertensive rat.
Clinical and experimental pharmacology & physiology 2003;30(9):627-31.
2003: David L Vesely
Natriuretic peptides and acute renal failure.
American journal of physiology. Renal physiology 2003;285(2):F167-77.
2002: Joaquin Gomez-Daspet; Lucinda Elko; Dmitry Grebenev; David L Vesely
Survival with serum sodium level of 180 mEq/L: permanent disorientation to place and time.
The American journal of the medical sciences 2002;324(6):321-5.
2002: Mukesh Kumar; Aruna K Behera; Richard F Lockey; David L Vesely; Shyam S Mohapatra
Atrial natriuretic peptide gene transfer by means of intranasal administration attenuates airway reactivity in a mouse model of allergic sensitization.
The Journal of allergy and clinical immunology 2002;110(6):879-82.
2002: David L Vesely; Gloria I San Miguel; Imran Hassan; Douglas D Schocken
Atrial natriuretic hormone, vessel dilator, long acting natriuretic hormone, and kaliuretic hormone decrease circulating prolactin concentrations.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2002;34(5):245-9.
2002: David L Vesely; Gloria I San Miguel; Imran Hassan; Douglas D Schocken
Intact negative feedback of four cardiac hormones in congestive heart failure.
Metabolism: clinical and experimental 2002;51(5):582-8.
2002: David L Vesely; Gloria I San Miguel; Imran Hassan; William R Gower; Douglas D Schocken
Four cardiac hormones increase circulating concentrations of luteinizing hormone and testosterone.
Endocrine 2002;17(2):145-50.
2001: David L Vesely; Gloria I San Miguel; Imran Hassan; William R Gower; Douglas D Schocken
Atrial natriuretic hormone, vessel dilator, long-acting natriuretic hormone, and kaliuretic hormone decrease the circulating concentrations of total and tree T4 and free T3 with reciprocal increase in TSH.
The Journal of clinical endocrinology and metabolism 2001;86(11):5438-42.
2001: David L Vesely; Gloria I San Miguel; Imran Hassan; Douglas D Schocken
Atrial natriuretic hormone, vessel dilator, long-acting natriuretic hormone, and kaliuretic hormone decrease the circulating concentrations of CRH, corticotropin, and cortisol.
The Journal of clinical endocrinology and metabolism 2001;86(9):4244-9.
2001: E Lawrence; S T Lord; Y Leon; P J McIntyre; J Penix; Dmitry Grebenev; David L Vesely
Tall cell papillary thyroid carcinoma metastatic to femur: evidence for thyroid hormone synthesis within the femur.
The American journal of the medical sciences 2001;322(2):103-8.
2001: A Nasser; JR Dietz; M Siddique; H Patel; N Khan; E K Antwi; Gloria I San Miguel; Michael T McCormick; Douglas D Schocken; David L Vesely
Effects of kaliuretic peptide on sodium and water excretion in persons with congestive heart failure.
The American journal of cardiology 2001;88(1):23-9.
2001: David L Vesely; GI Perez-Lamboy; Douglas D Schocken
Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance urinary excretion rate of albumin, total protein, and beta(2)-microglobulin in patients with congestive heart failure.
Journal of cardiac failure 2001;7(1):55-63.
2001: M D Vesely; William R Gower; GI Perez-Lamboy; RM Overton; L Graddy; David L Vesely
Evidence for an atrial natriuretic peptide-like gene in plants.
Experimental biology and medicine (Maywood, N.J.) 2001;226(1):61-5.
2000: David L Vesely; GI Perez-Lamboy; Douglas D Schocken
Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance the urinary excretion rate of beta2-microglobulin.
Metabolism: clinical and experimental 2000;49(12):1592-7.
2000: David L Vesely; P Mastrandrea; C Samson; G Argyelan; S Charvit
Post-herpes encephalitic anterior pituitary insufficiency with hypothermia and hypotension.
The American journal of the medical sciences 2000;320(4):273-7.
2000: M W Weston; R Vijayangar; RM Overton; David L Vesely
Prospective evaluation of the Batista procedure with circulating atrial natriuretic peptides.
International journal of cardiology 2000;74(2-3):145-52.
2000: A Cole; D Mendelblatt; J Aguayo; A Mathew; E Martin; David L Vesely
Metastatic prostate cancer (with prostate-specific antigen of 9996) presenting as obstructive jaundice.
The American journal of the medical sciences 2000;319(2):118-22.
2000: David L Vesely; GI Perez-Lamboy; Douglas D Schocken
Vessel dilator, long acting natriuretic peptide, and kaliuretic peptide increase circulating prostaglandin E2.
Life sciences 2000;66(10):905-13.
1999: David L Vesely; JR Dietz; JR Parks; E A Antwi; RM Overton; Michael T McCormick; G Cintron; Douglas D Schocken
Comparison of vessel dilator and long-acting natriuretic peptide in the treatment of congestive heart failure.
American heart journal 1999;138(4 Pt 1):625-32.
1999: David L Vesely; William R Gower; J R Dietz; RM Overton; Linda C Clark; E K Antwi; R V Farese
Elevated atrial natriuretic peptides and early renal failure in type 2 diabetic Goto-Kakizaki rats.
Metabolism: clinical and experimental 1999;48(6):771-8.
1998: David L Vesely; JR Dietz; JR Parks; M Baig; Michael T McCormick; G Cintron; Douglas D Schocken
Vessel dilator enhances sodium and water excretion and has beneficial hemodynamic effects in persons with congestive heart failure.
Circulation 1998;98(4):323-9.
1998: David L Vesely; RM Overton; M Blankenship; Michael T McCormick; Douglas D Schocken
Atrial natriuretic peptide increases urodilatin in the circulation.
American journal of nephrology 1998;18(3):204-13.
1997: S Daggubati; JR Parks; RM Overton; G Cintron; Douglas D Schocken; David L Vesely
Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators.
Cardiovascular research 1997;36(2):246-55.
1997: David L Vesely; RM Overton; Michael T McCormick; Douglas D Schocken
Atrial natriuretic peptides increase calcitonin gene-related peptide within human circulation.
Metabolism: clinical and experimental 1997;46(7):818-25.
1996: David L Vesely; Robert Sothern; L E Scheving; F W Bremner; J L Third; J B McCormick; S Dawson; S Kahn; G Augustine; M Ryan; J Greco; B A Nemchausky; P Shirazi; E L Kanabrocki
Circadian relationships between circulating atrial natriuretic peptides and serum calcium and phosphate in healthy humans.
Metabolism: clinical and experimental 1996;45(8):1021-8.
1996: David L Vesely; S Chiou; M A Douglass; Michael T McCormick; G Rodriguez-Paz; Douglas D Schocken
Atrial natriuretic peptides negatively and positively modulate circulating endothelin in humans.
Metabolism: clinical and experimental 1996;45(3):315-9.
1996: RM Overton; David L Vesely
Processing of long-acting natriuretic peptide and vessel dilator in human plasma and serum.
Peptides 1996;17(7):1155-62.
1996: Robert Sothern; David L Vesely; E L Kanabrocki; F W Bremner; J L Third; J B McCormick; S Dawson; M Ryan; J Greco; J T Bean; B M Nemchausky; P Shirazi; L E Scheving
Circadian relationships between circulating atrial natriuretic peptides and serum sodium and chloride in healthy humans.
American journal of nephrology 1996;16(6):462-70.
1996: David L Vesely; Richard A Preston; William R Gower; S Chiou; Murray Epstein
Increased release of kaliuretic peptide during immersion-induced central hypervolemia in cirrhotic humans.
American journal of nephrology 1996;16(2):128-37.
1996: RM Overton; David L Vesely
Processing of kaliuretic peptide in human plasma and serum.
Peptides 1996;17(6):1041-6.
1996: David L Vesely; M Blankenship; M A Douglass; Michael T McCormick; G Rodriguez-Paz; Douglas D Schocken
Atrial natriuretic peptide increases adrenomedullin in the circulation of healthy humans.
Life sciences 1996;59(3):243-54.
1995: David L Vesely; A T Giordano; M A Douglass; Michael T McCormick; G Rodriguez-Paz; Douglas D Schocken
Atrial natriuretic peptides and cyclic guanosine monophosphate metabolism.
The American journal of the medical sciences 1995;310(4):143-9.
1995: David L Vesely; S Chiou; M A Douglass; Michael T McCormick; G Rodriguez-Paz; Douglas D Schocken
Kaliuretic peptide and long acting natriuretic peptide as well as atrial natriuretic factor inhibit aldosterone secretion.
The Journal of endocrinology 1995;146(3):373-80.
1995: Robert Sothern; David L Vesely; E L Kanabrocki; F W Bremner; J L Third; M A Boles; B M Nemchausky; J H Olwin; L E Scheving
Blood pressure and atrial natriuretic peptides correlate throughout the day.
American heart journal 1995;129(5):907-16.
1995: David L Vesely; P Norsk; William R Gower; S Chiou; M Epstein
Release of kaliuretic peptide during immersion-induced central hypervolemia in healthy humans.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1995;209(1):20-6.
1995: S Chiou; David L Vesely
Kaliuretic peptide: the most potent inhibitor of Na(+)-K+ ATPase of the atrial natriuretic peptides.
Endocrinology 1995;136(5):2033-9.
1995: Robert Sothern; David L Vesely; E L Kanabrocki; R C Hermida; F W Bremner; J L Third; M A Boles; B M Nemchausky; J H Olwin; L E Scheving
Temporal (circadian) and functional relationship between atrial natriuretic peptides and blood pressure.
Chronobiology international 1995;12(2):106-20.
1995: B H Ackerman; Richard P Wyeth; Michael Soulsby; A A Pappas; David L Vesely
Vessel dilator is associated with survival after acute myocardial infarction.
International journal of cardiology 1995;47(3):235-44.
1994: David L Vesely; M A Douglass; John R Dietz; William R Gower; Michael T McCormick; G Rodriguez-Paz; Douglas D Schocken
Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce diuresis, natriuresis, and/or kaliuresis in humans.
Circulation 1994;90(3):1129-40.
1994: David L Vesely; M A Douglass; J R Dietz; A T Giordano; Michael T McCormick; G Rodriguez-Paz; Douglas D Schocken
Negative feedback of atrial natriuretic peptides.
The Journal of clinical endocrinology and metabolism 1994;78(5):1128-34.
1994: J Poulos; S R Johnson; P Conrad; J Montero; David L Vesely
Dome-shaped lesion on chest radiograph: retroperitoneal abscess dissecting through the posterior chest wall.
Southern medical journal 1994;87(1):77-80.
1994: M W Weston; G B Cintron; A T Giordano; David L Vesely
Normalization of circulating atrial natriuretic peptides in cardiac transplant recipients.
American heart journal 1994;127(1):129-42.
1994: William R Gower; S Chiou; K A Skolnick; David L Vesely
Molecular forms of circulating atrial natriuretic peptides in human plasma and their metabolites.
Peptides 1994;15(5):861-7.
1993: David L Vesely; William R Gower; A T Giordano
Atrial natriuretic peptides are present throughout the plant kingdom and enhance solute flow in plants.
The American journal of physiology 1993;265(3 Pt 1):E465-77.
1993: S R Saba; German Ramirez; David L Vesely
Immunocytochemical localization of ProANF 1-30, ProANF 31-67, atrial natriuretic factor and urodilatin in the human kidney.
American journal of nephrology 1993;13(2):85-93.
1992: B H Ackerman; Richard P Wyeth; David L Vesely; W L Ngo; J K Bissett; C J Winters; A L Sallman
Pharmacokinetic characterization of the postdistribution phase of prohormone atrial natriuretic peptides amino acids 1-98, 31-67, and atrial natriuretic factor during and after rapid right ventricular pacing in dogs.
Journal of clinical pharmacology 1992;32(5):415-21.
1992: German Ramirez; S R Saba; J R Dietz; David L Vesely
Immunocytochemical localization of proANF 1-30, proANF 31-67 and atrial natriuretic factor in the kidney.
Kidney international 1992;41(2):334-41.
1992: David L Vesely
Peptides from the N-terminus of the atrial natriuretic factor prohormone enhance guanylate cyclase activity and increase cyclic GMP levels in a wide variety of tissues.
Molecular and cellular biochemistry 1992;109(1):43-50.
1992: David L Vesely; A T Giordano
Atrial natriuretic factor-like peptide and its prohormone within single cell organisms.
Peptides 1992;13(1):177-82.
1992: R W McMurray; David L Vesely
Weight reduction decreases the circulating concentration of the N-terminus of the ANF prohormone.
The American journal of the medical sciences 1992;303(1):2-8.
1992: David L Vesely; A L Sallman; J M Bayliss
Specific binding site for pro atrial natriuretic factors 1-30, 31-67, and 99-126 on distal nephrons, proximal tubules, renal cortical and medullary membranes.
Renal physiology and biochemistry 1992;15(1):23-32.
1991: B J Baker; W C Wu; C J Winters; H Dinh; Richard P Wyeth; A L Sallman; David L Vesely
Exercise increases the circulating concentration of the N-terminus of the atrial natriuretic factor prohormone in normal individuals.
American heart journal 1991;122(5):1395-402.
1991: David L Vesely
Aprotinin blocks the binding of pro atrial natriuretic peptides 1 to 30, 31 to 67, and 99 to 126 to human placental membranes.
American journal of obstetrics and gynecology 1991;165(3):567-73.
1991: David L Vesely; A T Giordano
Atrial natriuretic peptide hormonal system in plants.
Biochemical and biophysical research communications 1991;179(1):695-700.
1991: R W Merkouris; F C Miller; V Catanzarite; J Gerald Quirk; L A Rigg; David L Vesely
The N-terminal and C-terminal portions of the atrial natriuretic factor prohormone increase during preeclampsia.
American journal of obstetrics and gynecology 1991;164(5 Pt 1):1197-202.
1991: L Ngo; David L Vesely; J K Bissett; M L Murphy; H Dinh; A L Sallman; D M Rico; C J Winters; Richard P Wyeth
Acute and sustained release of the atrial natriuretic factor prohormone N-terminus with acute myocardial infarction.
The American journal of the medical sciences 1991;301(3):157-64.
1991: David L Vesely; A T Giordano
Food intake and body positional change alter the circadian rhythm of atrial natriuretic peptides excretion into human urine.
Chronobiology international 1991;8(5):373-84.
1991: David L Vesely; Richard A Preston; C J Winters; D M Rico; A L Sallman; Murray Epstein
Increased release of the N-terminal and C-terminal portions of the atrial natriuretic factor prohormone during immersion-induced central hypervolemia in cirrhotic humans.
American journal of nephrology 1991;11(3):207-16.
1990: Richard P Wyeth; B H Ackerman; David L Vesely
The N-terminus, C-terminus, and vessel dilator of the ANF prohormone are present in the urine and increase with ventricular fibrillation.
Biochemical and biophysical research communications 1990;173(3):1030-7.
1990: D M Rico; F J Svendsen; C Huffer; M Smith; R Pierce; C J Winters; David L Vesely
Increased release of the N-terminus of the atrial natriuretic factor prohormone with increasing absolute atmospheres of pressure in a hyperbaric chamber and reversal with oxygen therapy.
Chest 1990;98(6):1403-7.
1990: David L Vesely; W C Arnold; C J Winters; A L Sallman; D M Rico
Increased circulating concentration of the N-terminus of the atrial natriuretic factor prohormone in persons with pheochromocytomas.
The Journal of clinical endocrinology and metabolism 1990;71(5):1138-46.
1990: L Ngo; J K Bissett; C J Winters; David L Vesely
Plasma prohormone atrial natriuretic peptides 1-98 and 31-67 increase with supraventricular and ventricular arrhythmias.
The American journal of the medical sciences 1990;300(2):71-7.
1990: David L Vesely; C J Winters; A L Sallman
The N-terminus of the atrial natriuretic factor prohormone in the pleural fluid of congestive heart failure patients.
Chest 1990;97(6):1295-8.
1990: D R Martin; J B Pevahouse; D J Trigg; David L Vesely; J E Buerkert
Three peptides from the ANF prohormone NH(2)-terminus are natriuretic and/or kaliuretic.
The American journal of physiology 1990;258(5 Pt 2):F1401-8.
1990: David L Vesely; Lawrence Cornett; S L MacLeod; A A Nash; james norris
Specific binding sites for prohormone atrial natriuretic peptides 1-30, 31-67 and 99-126.
Peptides 1990;11(2):193-7.
1990: R W Merkouris; F C Miller; V Catanzarite; L A Rigg; J Gerald Quirk; David L Vesely
Increase in the plasma levels of the N-terminal and C-terminal portions of the prohormone of atrial natriuretic factor during normal pregnancy.
American journal of obstetrics and gynecology 1990;162(3):859-64.
1990: David L Vesely; J S Salmon
Mechanical ventilation with positive end-expiratory pressure decreases the circulating concentrations of the N-terminus and C-terminus of the atrial natriuretic factor prohormone.
Respiration; international review of thoracic diseases 1990;57(6):389-94.
1990: David L Vesely; C J Winters
Presence of the N-terminal and C-terminal portions of the prohormone of atrial natriuretic factor in the ascitic fluid of cirrhotic patients.
Journal of medicine 1990;21(5):265-75.
1990: David L Vesely; E L Kanabrocki; Robert Sothern; L E Scheving; T H Tsai; J Greco; D L Bushell; E Kaplan; J Rumbyrt; R P Sturtevant
The circadian rhythm of the N-terminus and C-terminus of the atrial natriuretic factor prohormone.
Chronobiology international 1990;7(1):51-7.
1990: E L Kanabrocki; Robert Sothern; L E Scheving; David L Vesely; T H Tsai; J Shelstad; C Cournoyer; J Greco; H Mermall; H Ferlin
Reference values for circadian rhythms of 98 variables in clinically healthy men in the fifth decade of life.
Chronobiology international 1990;7(5-6):445-61.
1989: David L Vesely; P Norsk; C J Winters; D M Rico; A L Sallman; M Epstein
Increased release of the N-terminal and C-terminal portions of the prohormone of atrial natriuretic factor during immersion-induced central hypervolemia in normal humans.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1989;192(3):230-5.
1989: C J Winters; B J Baker; H Dinh; A L Sallman; D M Rico; David L Vesely
Prohormone atrial natriuretic peptides 1-98 and 31-67 increase with exercise in congestive heart failure patients.
The American journal of the medical sciences 1989;298(6):377-82.
1989: R W McMurray; David L Vesely
Weight reduction decreases atrial natriuretic factor and blood pressure in obese patients.
Metabolism: clinical and experimental 1989;38(12):1231-7.
1989: S S Beland; David L Vesely; W C Arnold; H K Beavers; S R Gilbert; G N Henson; Michael R Williamson
Localization of adrenal and extra-adrenal pheochromocytomas by magnetic resonance imaging.
Southern medical journal 1989;82(11):1410-3.
1989: L Ngo; David L Vesely; J K Bissett; M L Murphy; H Dinh; R Seth; A L Sallman; D M Rico; C J Winters; Richard P Wyeth
Acute and sustained release of atrial natriuretic factor with acute myocardial infarction.
American heart journal 1989;118(5 Pt 1):893-900.
1989: D S Bradford; M Keppen; A L Sallman; H Dinh; David L Vesely
Increased plasma concentration of atrial natriuretic factor with squamous cell carcinoma invasion of the right and left atria of the heart.
Cancer 1989;64(9):1909-13.
1989: C J Winters; A L Sallman; B J Baker; J Meadows; D M Rico; David L Vesely
The N-terminus and a 4,000-MW peptide from the midportion of the N-terminus of the atrial natriuretic factor prohormone each circulate in humans and increase in congestive heart failure.
Circulation 1989;80(3):438-49.
1989: David L Vesely
Hypothalamic sarcoidosis: a new cause of morbid obesity.
Southern medical journal 1989;82(6):758-61.
1989: David L Vesely; C J Winters; A L Sallman
Atrial natriuretic factor in the pleural fluid of congestive heart failure patients.
Chest 1989;95(5):1107-9.
1989: David L Vesely; C J Winters; A L Sallman
Prohormone atrial natriuretic peptides 1-30 and 31-67 increase in hyperthyroidism and decrease in hypothyroidism.
The American journal of the medical sciences 1989;297(4):209-15.
1989: L Ngo; Richard P Wyeth; J K Bissett; W L Hester; M T Newton; A L Sallman; C J Winters; David L Vesely
Prohormone atrial natriuretic peptides 1-30, 31-67, and 99-126 increase in proportion to right ventricular pacing rate.
American heart journal 1989;117(2):385-90.
1989: David L Vesely; W C Arnold; C J Winters; A L Sallman; D M Rico
Increased circulating concentration of atrial natriuretic factor in persons with pheochromocytomas.
Clinical and experimental hypertension. Part A, Theory and practice 1989;11(3):353-69.
1989: D M Rico; F J Svendsen; C Huffer; M Smith; R Pierce; C J Winters; David L Vesely
Release of atrial natriuretic factor with increasing absolute atmospheres of pressure in a hyperbaric chamber and reversal with oxygen therapy.
Journal of medicine 1989;20(5-6):337-47.
1988: D A Baeyens; J M Walters; David L Vesely
Atrial natriuretic factor increases the magnitude of duodenal spontaneous phasic contractions.
Biochemical and biophysical research communications 1988;155(3):1437-43.
1988: David L Vesely
Selective pituitary resistance to thyroid hormone after treatment of a toxic multinodular goiter.
Southern medical journal 1988;81(9):1173-6.
1988: G M Barton; W B Shoup; W G Bennett; J B Williams; David L Vesely
Combined Escherichia coli and Staphylococcus aureus thyroid abscess in an asymptomatic man.
The American journal of the medical sciences 1988;295(2):133-6.
1988: C J Winters; A L Sallman; J Meadows; D M Rico; David L Vesely
Two new hormones: prohormone atrial natriuretic peptides 1-30 and 31-67 circulate in man.
Biochemical and biophysical research communications 1988;150(1):231-6.
1988: C J Winters; A L Sallman; David L Vesely
Circadian rhythm of prohormone atrial natriuretic peptides 1-30, 31-67 and 99-126 in man.
Chronobiology international 1988;5(4):403-9.
1987: David L Vesely; james norris; J M Walters; R R Jespersen; D A Baeyens
Atrial natriuretic prohormone peptides 1-30, 31-67, and 79-98 vasodilate the aorta.
Biochemical and biophysical research communications 1987;148(3):1540-8.
1987: J K Jenkins; T R Best; S A Nicks; F Y Murphy; K L Bussell; David L Vesely
Milk-alkali syndrome with a serum calcium level of 22 mg/dl and J waves on the ECG.
Southern medical journal 1987;80(11):1444-9.
1987: F Y Murphy; David L Vesely; R M Jordan; S Flanigan; Peter O Kohler
Giant invasive prolactinomas.
The American journal of medicine 1987;83(5):995-1002.
1987: W G Bennett; R A Watson; J K Heard; David L Vesely
Home hyperalimentation for common variable hypogammaglobulinemia with malabsorption secondary to intestinal nodular lymphoid hyperplasia.
The American journal of gastroenterology 1987;82(10):1091-5.
1987: T R Best; J K Jenkins; F Y Murphy; S A Nicks; K L Bussell; David L Vesely
Persistent adrenal insufficiency secondary to low-dose ketoconazole therapy.
The American journal of medicine 1987;82(3 Spec No):676-80.
1987: David L Vesely; J M Bayliss; A L Sallman
Human prepro atrial natriuretic factors 26-55, 56-92, and 104-123 increase renal guanylate cyclase activity.
Biochemical and biophysical research communications 1987;143(1):186-93.
1987: K L Bussell; F Y Murphy; S A Nicks; David L Vesely
Facial flushing secondary to hypoglycemia.
Journal of medicine 1987;18(2):123-32.
1987: David L Vesely; L L Sanders
False elevation of hemoglobin A1 by hereditary persistence of fetal hemoglobin.
Journal of medicine 1987;18(2):81-92.
1985: David L Vesely; M J Coleman; Peter O Kohler; R M Jordan; S Stanley
Hyperalimentation as cause of markedly worsened metabolic control in a patient with autoantibodies to the insulin receptor.
The American journal of medicine 1985;79(4):504-8.